blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3031460

EP3031460 - BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.05.2021
Database last updated on 13.11.2024
FormerExamination is in progress
Status updated on  26.01.2018
FormerRequest for examination was made
Status updated on  23.12.2016
Most recent event   Tooltip21.05.2021Application deemed to be withdrawnpublished on 23.06.2021  [2021/25]
Applicant(s)For all designated states
Cempra Pharmaceuticals Inc.
6320 Quadrangle Drive
Suite 360
Chapel Hill, NC 27517 / US
[2016/24]
Inventor(s)01 / Fernandes, Prabhavathi, B.
114 Milton Avenue
Chapel Hill, NC North Carolina 27514 / US
 [2016/24]
Representative(s)Elsy, David
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2016/24]Elsy, David
Withers & Rogers LLP
4 More London Riverside
London SE1 2AU / GB
Application number, filing date15186676.124.10.2009
[2016/24]
Priority number, dateUS20080108137P24.10.2008         Original published format: US 108137 P
US20080108110P24.10.2008         Original published format: US 108110 P
US20080108168P24.10.2008         Original published format: US 108168 P
US20080108112P24.10.2008         Original published format: US 108112 P
US20080108134P24.10.2008         Original published format: US 108134 P
US20090162109P20.03.2009         Original published format: US 162109 P
[2016/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3031460
Date:15.06.2016
Language:EN
[2016/24]
Search report(s)(Supplementary) European search report - dispatched on:EP03.05.2016
ClassificationIPC:A61K31/70, A61K31/04, A61K31/7052, A61P31/00
[2016/24]
CPC:
A61K31/7048 (EP,US); A61K31/7056 (EP,CN,US); A61K31/424 (EP,US);
A61K31/70 (EP,US); A61K31/7052 (EP,US); A61K31/706 (CN);
A61P1/00 (EP); A61P1/04 (EP); A61P11/00 (EP);
A61P29/00 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P33/02 (EP); C07D498/04 (EP,US); C07H17/08 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/04]
Former [2016/24]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:BIOABWEHR UNTER VERWENDUNG TRIAZOLHALTIGER MAKROLIDE[2016/24]
English:BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES[2016/24]
French:BIODÉFENSES UTILISANT DES MACROLIDES CONTENANT DES TRIAZOLES[2016/24]
Examination procedure24.09.2015Date on which the examining division has become responsible
14.12.2016Amendment by applicant (claims and/or description)
14.12.2016Examination requested  [2017/04]
25.01.2018Despatch of a communication from the examining division (Time limit: M06)
02.08.2018Reply to a communication from the examining division
08.02.2019Despatch of a communication from the examining division (Time limit: M06)
22.11.2019Reply to a communication from the examining division
17.09.2020Despatch of a communication from the examining division (Time limit: M04)
28.01.2021Application deemed to be withdrawn, date of legal effect  [2021/25]
17.02.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/25]
Parent application(s)   TooltipEP09822828.1  / EP2358379
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
22.11.2019Request for further processing filed
22.11.2019Full payment received (date of receipt of payment)
Request granted
03.12.2019Decision despatched
Fees paidRenewal fee
24.09.2015Renewal fee patent year 03
24.09.2015Renewal fee patent year 04
24.09.2015Renewal fee patent year 05
24.09.2015Renewal fee patent year 06
24.09.2015Renewal fee patent year 07
19.10.2016Renewal fee patent year 08
30.10.2017Renewal fee patent year 09
24.10.2018Renewal fee patent year 10
30.04.2020Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.10.201911   M06   Fee paid on   30.04.2020
31.10.202012   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2003176327  (CASSELL GAIL HOUSTON [US], et al) [A] 1-13* the whole document *;
 [AD]US2006100164  (LIANG CHANG-HSING [US], et al) [AD] 1-13 * the whole document *;
 [A]  - LIANG C H ET AL, "Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 15, no. 5, doi:10.1016/J.BMCL.2005.01.027, ISSN 0960-894X, (20050301), pages 1307 - 1310, (20050301), XP025314537 [A] 1-13 * figures 3, 4; table 1 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2005.01.027
by applicantUS2006100164
 WO2009055557
    - DRUSANO ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERASPY, (200811), vol. 52, no. 11, pages 3973 - 3979
    - INGLESBY ET AL., JAMA, (2002), vol. 287, no. 17, pages 2236 - 2252
    - LEMAIRE ET AL., ANTIMICROB. AGENTS. CHEMOTHER., (2009), vol. 53, pages 3734 - 3743
    - AAC, (2006), vol. 50, pages 841 - 51
    - AAC, (2007), vol. 51, pages 2748 - 57
    - AAC, (2006), vol. 50, pages 841 - 851
    - BARCIA-MACAY ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2006), vol. 50, pages 841 - 851
    - BARCIA-MACAY ET AL., "Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages Antimicrob", AGENTS CHEMOTHER., (2006), vol. 50, pages 841 - 851
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.